−5JPY
138.26 MJPY
8.66 BJPY
16.39 M
About WAKAMOTO PHARMACEUTICAL CO
Sector
Headquarters
Tokyo
Employees (FY)
292
Website
Founded
1929
ISIN
JP3991200001
FIGI
BBG000BCWM24
Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical and non-prescription drugs. Its operations are carried out through the following segments: Medicine, Non-Prescription Drugs, Special Sales and Others. The Medicine segment provides ethical drugs. The Non-Prescription Drugs segment offers over-the-counter (OTC) drugs, quasi drugs and health food products. The Special Sales segment deals with the manufacture and sale of pharmaceutical raw materials, export products, intermediate products, and other products for pharmaceutical companies. The Others segment includes real estate leasing business. The company was founded in April 1929 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4512 is 233 JPY — it has increased by 1.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange WAKAMOTO PHARMACEUTICAL CO stocks are traded under the ticker 4512.
WAKAMOTO PHARMACEUTICAL CO is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
4512 stock is 3.98% volatile and has beta coefficient of −0.03. Check out the list of the most volatile stocks — is WAKAMOTO PHARMACEUTICAL CO there?
Yes, you can track WAKAMOTO PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
4512 stock has fallen by 0.43% compared to the previous week, the month change is a 11.48% rise, over the last year WAKAMOTO PHARMACEUTICAL CO has showed a 5.28% decrease.
4512 net income for the last quarter is 17.26 M JPY, while the quarter before that showed −323.53 M JPY of net income which accounts for 105.34% change. Track more WAKAMOTO PHARMACEUTICAL CO financial stats to get the full picture.
Today WAKAMOTO PHARMACEUTICAL CO has the market capitalization of 7.95 B, it has increased by 2.19% over the last week.
WAKAMOTO PHARMACEUTICAL CO dividend yield was 1.21% in 2022, and payout ratio reached 75.31%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4512 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WAKAMOTO PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 292.00 employees. See our rating of the largest employees — is WAKAMOTO PHARMACEUTICAL CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WAKAMOTO PHARMACEUTICAL CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WAKAMOTO PHARMACEUTICAL CO stock shows the neutral signal. See more of WAKAMOTO PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WAKAMOTO PHARMACEUTICAL CO EBITDA is 258.71 M JPY, and current EBITDA margin is 5.83%. See more stats in WAKAMOTO PHARMACEUTICAL CO financial statements.